Close

Ratings by Oppenheimer (Matthew Biegler)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/21/2024 Vor Biopharma, Inc. VOR Maintain Outperform
(N/A)
 
 
  Details
3/12/2024 ORIC Pharamceuticals ORIC Maintain Outperform
(N/A)
 
 
  Details
2/28/2024 Arvinas Inc. ARVN Maintain Outperform
(N/A)
 
 
  Details
2/20/2024 Ideaya Biosciences IDYA Maintain Outperform
(N/A)
 
 
  Details
1/31/2024 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
10/27/2023 Blueprint Medicines BPMC Upgrade Outperform
(Perform)
55.22
(86.09)
55.9% Details
8/11/2023 Ideaya Biosciences IDYA Maintain Outperform
(N/A)
 
 
  Details
8/11/2023 Aptose Biosciences APTO Maintain Outperform
(N/A)
 
 
  Details
7/21/2023 Olema Pharmaceuticals OLMA New Coverage Outperform
(N/A)
9.14
(10.82)
18.38% Details
6/26/2023 Nurix NRIX New Coverage Outperform
(N/A)
10.19
(14.65)
43.77% Details
6/26/2023 Arvinas Inc. ARVN New Coverage Outperform
(N/A)
26.79
(33.44)
24.82% Details
6/12/2023 Aptose Biosciences APTO Maintain Outperform
(N/A)
 
 
  Details
6/2/2023 Acrivon Therapeutics Inc ACRV New Coverage Outperform
(N/A)
11.78
(9.47)
-19.61% Details
6/2/2023 Ambrx Biopharma AMAM New Coverage Outperform
(N/A)
14.76
(28.00)
89.7% Details
5/16/2023 Fulcrum Therapeutics FULC Maintain Outperform
(N/A)
 
 
  Details
4/24/2023 Ideaya Biosciences IDYA Maintain Outperform
(N/A)
 
 
  Details
3/16/2023 ORIC Pharamceuticals ORIC Upgrade Outperform
(Perform)
4.65
(9.45)
103.23% Details
2/27/2023 Fulcrum Therapeutics FULC Maintain Outperform
(N/A)
 
 
  Details
12/22/2022 Nkarta Inc. NKTX Downgrade Perform
(Outperform)
5.88
(7.79)
32.48% Details
12/22/2022 Fate Therapeutics FATE Downgrade Perform
(Outperform)
12.25
(5.38)
-56.08% Details
12/22/2022 Celularity CELU Downgrade Perform
(Outperform)
1.28
(3.50)
173.44% Details
12/12/2022 Fate Therapeutics FATE Maintain Outperform
(N/A)
 
 
  Details
11/30/2022 Portage Biotech inc. PRTG Maintain Outperform
(N/A)
 
 
  Details
11/14/2022 Celularity CELU Maintain Outperform
(N/A)
 
 
  Details
11/14/2022 Vor Biopharma, Inc. VOR Maintain Outperform
(N/A)
 
 
  Details
11/10/2022 Nkarta Inc. NKTX Maintain Outperform
(N/A)
 
 
  Details
11/9/2022 Fulcrum Therapeutics FULC Maintain Outperform
(N/A)
 
 
  Details
11/2/2022 Blueprint Medicines BPMC Downgrade Perform
(Outperform)
48.24
(86.09)
78.46% Details
9/7/2022 Blueprint Medicines BPMC Maintain Outperform
(N/A)
 
 
  Details
9/1/2022 Ideaya Biosciences IDYA Maintain Outperform
(N/A)
 
 
  Details
8/16/2022 Ideaya Biosciences IDYA Maintain Outperform
(N/A)
 
 
  Details
8/10/2022 Medicenna Therapeutics MDNA Maintain Outperform
(N/A)
 
 
  Details
7/18/2022 Portage Biotech inc. PRTG New Coverage Outperform
(N/A)
9.01
(0.28)
-96.89% Details
7/18/2022 ORIC Pharamceuticals ORIC New Coverage Perform
(N/A)
4.27
(9.45)
121.31% Details
7/18/2022 Ideaya Biosciences IDYA New Coverage Outperform
(N/A)
15.50
(41.17)
165.61% Details
7/8/2022 Blueprint Medicines BPMC New Coverage Outperform
(N/A)
54.28
(86.09)
58.6% Details
6/23/2022 Medicenna Therapeutics MDNA Maintain Outperform
(N/A)
 
 
  Details
6/3/2022 Turning Point Therapeutics Inc. TPTX Downgrade Perform
(Outperform)
34.16
(76.01)
122.51% Details
3/18/2022 Nkarta Inc. NKTX Maintain Outperform
(N/A)
 
 
  Details
3/15/2022 Vor Biopharma, Inc. VOR Maintain Outperform
(N/A)
 
 
  Details
3/8/2022 Fulcrum Therapeutics FULC New Coverage Outperform
(N/A)
13.03
(7.41)
-43.13% Details
2/22/2022 Homology Medicines FIXX Downgrade Perform
(Outperform)
3.86
(0.93)
-75.91% Details
2/17/2022 Marker Therapeutics MRKR Maintain Outperform
(N/A)
 
 
  Details
1/28/2022 Celularity CELU New Coverage Outperform
(N/A)
4.17
(3.50)
-16.07% Details
1/21/2022 Turning Point Therapeutics Inc. TPTX Maintain Outperform
(N/A)
 
 
  Details
12/2/2021 Vor Biopharma, Inc. VOR New Coverage Outperform
(N/A)
11.54
(1.71)
-85.18% Details
11/16/2021 Fate Therapeutics FATE Maintain Outperform
(N/A)
 
 
  Details
11/10/2021 Turning Point Therapeutics Inc. TPTX Maintain Outperform
(N/A)
 
 
  Details
10/13/2021 Homology Medicines FIXX Maintain Outperform
(N/A)
 
 
  Details
7/16/2021 Nkarta Inc. NKTX New Coverage Outperform
(N/A)
27.77
(7.79)
-71.95% Details
4/6/2021 Turning Point Therapeutics Inc. TPTX Maintain Outperform
(N/A)
 
 
  Details
3/24/2021 Aptose Biosciences APTO Maintain Outperform
(N/A)
 
 
  Details
1/19/2021 Fate Therapeutics FATE Maintain Outperform
(N/A)
 
 
  Details
1/12/2021 Turning Point Therapeutics Inc. TPTX Maintain Outperform
(N/A)
 
 
  Details
12/18/2020 Medicenna Therapeutics MDNA New Coverage Outperform
(N/A)
3.82
(0.16)
-95.81% Details
11/13/2020 Turning Point Therapeutics Inc. TPTX Maintain Outperform
(N/A)
 
 
  Details
11/9/2020 Fate Therapeutics FATE Maintain Outperform
(N/A)
 
 
  Details
10/26/2020 Turning Point Therapeutics Inc. TPTX Maintain Outperform
(N/A)
 
 
  Details
8/11/2020 Marker Therapeutics MRKR Maintain Outperform
(N/A)
 
 
  Details
8/11/2020 Homology Medicines FIXX Maintain Outperform
(N/A)
 
 
  Details
7/10/2020 Turning Point Therapeutics Inc. TPTX New Coverage Outperform
(N/A)
62.77
(34.16)
-45.58% Details
6/10/2020 Fate Therapeutics FATE Maintain Outperform
(Outperform)
 
 
  Details
3/16/2020 Homology Medicines FIXX Upgrade Outperform
(Perform)
14.06
(0.93)
-93.39% Details
3/11/2020 Aptose Biosciences APTO Maintain Outperform
(N/A)
 
 
  Details
2/12/2020 Marker Therapeutics MRKR Maintain Outperform
(N/A)
 
 
  Details
1/17/2020 Aptose Biosciences APTO Maintain Outperform
(N/A)
 
 
  Details
12/9/2019 Fate Therapeutics FATE Maintain Outperform
(N/A)
 
 
  Details
11/13/2019 Marker Therapeutics MRKR Maintain Outperform
(N/A)
 
 
  Details
11/1/2019 Homology Medicines FIXX New Coverage Perform
(N/A)
12.84
(14.06)
9.5% Details
7/3/2019 Marker Therapeutics MRKR New Coverage Outperform
(N/A)
8.07
(4.40)
-45.48% Details
1/25/2019 Aptose Biosciences APTO New Coverage Outperform
(N/A)
2.08
(1.27)
-38.94% Details